Home >> Signaling Pathways >> Apoptosis

Apoptosis(凋亡)

As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.

Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.

Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.

Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.

Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.

Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.

One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.

p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.

Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9). 

Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.

References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.

Products for  Apoptosis

  1. Cat.No. 产品名称 Information
  2. GC41700 (E)-2-(2-Chlorostyryl)-3,5,6-trimethylpyrazine

    CSTMP

    A stilbene derivative with antioxidant and anticancer activities
  3. GC41698 (D)2-Rh 110 (trifluoroacetate salt)

    D2R, (Asp)2-Rhodamine 110, Rhodamine 110 bis-(L-aspartic acid amide)

    A fluorogenic caspase substrate
  4. GC41645 Jacaric Acid

    8(Z),10(E),12(Z)-Octadecatrienoic Acid

    A conjugated PUFA
  5. GC41643 9(Z),11(E),13(E)-Octadecatrienoic Acid

    αEleostearic Acid, αESA, LAF 237

    A polyunsaturated fatty acid
  6. GC41642 9(E),11(E),13(E)-Octadecatrienoic Acid

    β-Eleostearic Acid, β-ESA

    A polyunsaturated fatty acid
  7. GC41640 Asterriquinol D dimethyl ether A fungal metabolite
  8. GC41623 β-Elemonic Acid

    β-岚香酮酸

    A triterpene with anticancer activity
  9. GC41612 2'-O-Methylguanosine

    2'-甲氧基鸟苷

    A modified nucleoside
  10. GC41595 Matairesinol

    罗汉松脂素

    A lignan with diverse biological activities
  11. GC41584 Penicolinate A

    Penicolinate B dimethyl ester

    A fungal metabolite with diverse biological activities
  12. GC41564 MPT0B014 An inhibitor of tubulin polymerization
  13. GC41557 (S)-3'-amino Blebbistatin

    (-)-3'-amino Blebbistatin, m-amino Blebbistatin, meta-amino Blebbistatin

    A more stable form of (–)-blebbistatin
  14. GC41533 Silybin

    水飞蓟宾

    Hepatoprotective flavonoid and 5-LO inhibitor
  15. GC41514 Citreoviridin

    黄绿青霉素

    A mycotoxin that inhibits the mitochondrial ATPase
  16. GC41499 α-Phellandrene

    水芹烯

    A monoterpene with diverse biological activities
  17. GC41484 (S)-3'-hydroxy Blebbistatin

    (-)-3'-hydroxy Blebbistatin, meta-hydroxy-Blebbistatin, m-hydroxy-Blebbistatin

    A more stable form of (–)-blebbistatin
  18. GC41466 Reveromycin A

    雷弗霉素A

    A spiroketal antibiotic with antiproliferative activity
  19. GC41452 Luteoloside

    木犀草苷; Luteolin 7-glucoside; Luteolin 7-O-β-D-glucoside

    A flavanoid with diverse biological activities
  20. GC41409 Valilactone

    缬基内酯,(-)-Valilactone

    An esterase inhibitor
  21. GC41384 K-TMZ A DNA alkylating agent
  22. GC41345 (-)-α-Bisabolol

    没药醇; (-)-α-Bisabolol

    A sesquiterpene alcohol with diverse biological activities
  23. GC41342 Terrecyclic Acid

    环酸A

    A sesquiterpene
  24. GC41341 Quadrone

    夸德尔酮

    A sesquiterpene with anticancer activity
  25. GC41340 Illudin M

    隐陡头菌素M

    A DNA alkylating agent
  26. GC41317 CAY10625 An inhibitor of survivin - Smac/DIABLO interaction
  27. GC41268 (E)-2-Hexadecenal

    trans-2-Hexadecenal

    A long-chain fatty aldehyde
  28. GC41261 Flavokawain B

    黄卡瓦胡椒素B,Flavokavain B

    Induces cancer cell apoptosis
  29. GC41183 α-Carotene

    α-胡萝卜素

    A precursor of vitamin A

  30. GC41114 Necrostatin-5

    2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-D]嘧啶-2-基]硫代]-乙腈

    A RIP1 kinase inhibitor
  31. GC41112 Dihydroxy Melphalan

    二羟基美法兰

    An inactive degradation product of melphalan
  32. GC41102 15-deoxy-δ12,14-Prostaglandin D2

    15deoxyΔ12,14PGD2

    A metabolite of PGD2 and an agonist of DP2
  33. GC41080 Albofungin

    白真菌素

    A xanthone with diverse biological activities
  34. GC40986 Cinnamamide

    肉桂酰胺

    An amide of trans-cinnamic acid
  35. GC40947 2,3-Dimethoxy-5-methyl-p-benzoquinone

    2,3-二甲氧基-5-甲基-1,4-苯醌,CoQ0

    An intermediate in the synthesis of ubiquinones that has anticancer activity
  36. GC40932 S-trityl-L-Cysteine

    NSC 83265; S-Tritylcysteine; 3-Tritylthio-L-alanine

    An inhibitor of Eg5
  37. GC40909 Lonicerin

    忍冬苦苷

    A flavonoid with diverse biological activities
  38. GC40901 Isogarcinol

    Cambogin

    A natural benzophenone that has immunosuppressant actions
  39. GC40878 Chelidonine

    白屈菜碱

    A tertiary hexahydro-benzophenanthridine alkaloid
  40. GC40872 Zinquin ethyl ester

    乙基2-(2-甲基-8-(4-甲基苯基磺酸基N乙酰胺基)喹啉-6-氧基)乙酸酯

    A fluorescent probe for zinc

  41. GC40865 LYG-202 A synthetic flavonoid with anticancer and anti-angiogenic activities
  42. GC40861 Pinosylvin

    赤松素

    A stilbene with diverse biological activities
  43. GC40859 Steffimycin B

    司替霉素B

    An anthracycline bacterial metabolite
  44. GC40791 MS-1020 A cell-permeable inhibitor of JAK3
  45. GC40785 9(Z),11(E),13(E)-Octadecatrienoic Acid ethyl ester

    αESA ethyl ester, Ethyl αeleostearate

    A polyunsaturated fatty acid ethyl ester
  46. GC40760 Nonanoic Acid methyl ester

    壬酸甲酯

    An esterified form of nonanoic acid
  47. GC40758 Gly-Phe-β-naphthylamide

    (S)-2-(2-氨基乙酰氨基)-N-(萘-2-基)-3-苯基丙酰胺

    A cathepsin C substrate
  48. GC40715 Ascochlorin

    壳二孢氯素,Ilicicolin D

    An isoprenoid antibiotic and antiviral
  49. GC40710 9(Z),11(E),13(E)-Octadecatrienoic Acid methyl ester

    9顺,11反,13反-十八碳三烯酸甲酯

    A polyunsaturated fatty acid methyl ester
  50. GC40698 (-)-Perillyl Alcohol

    紫苏醇

    A monoterpene alcohol with diverse biological activities
  51. GC40690 C6 L-threo Ceramide (d18:1/6:0)

    L-threo Cer(d18:1/6:0), L-threo Ceramide (d18:1/6:0), N-hexanoyl-L-threo-Sphingosine

    A bioactive sphingolipid

Items 1601 to 1650 of 2733 total

per page

Set Descending Direction